Live Chat

Perdagangan JnJ JNJ

JnJ diagram langsung

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Berita Terkini

Hand holding mobile with Tesla logo and upward stock arrow, reflecting Tesla Model Y price increase.
Vanessa L 2025 Jan 23, 11:00

Tesla Model Y Price Hike Sparks Debate Across Canada

TSLA Stocks Shares
Gold bullion and U.S. dollar bills, reflecting trends in gold coin prices.
Vanessa L 2025 Jan 23, 10:20

Gold Coin Prices Steady Amid Dollar Weakness

Gold USD Commodities Fed
Apple stock news with Chinese flag on smartphone, highlighting market challenges.
Vanessa L 2025 Jan 23, 08:30

Apple Stock News Amid Revenue Diversification

Stocks Shares AAPL China
BOJ rate hike
Tommy Yap 2025 Jan 22, 17:00

Morning Note: BOJ’s Rate Hike: How Will It Shape Markets?

BoJ Forex
Netflix app logo on smartphone, representing "do Netflix stocks stay good or bad."
Vanessa L 2025 Jan 22, 12:30

Trump Stock Market & Netflix Stock Outlook

Stocks US500 USD Shares
Oil prices
Tommy Yap 2025 Jan 21, 17:00

Morning Note: How Trump's Energy Plan and Global Market Trends Are Shaping Investments

Oil
Frances Wang 2025 Jan 21, 16:00

NFLX stock News today: Netflix stock jumped over 14%

Stocks
Frances Wang 2025 Jan 21, 16:00

Dow Jones rises ahead of potential interest rate cuts

Indices

Info

Spread

0.91

Spread (%)

0.6228 %

Leverage

1:2

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Jumat

14:31 - 20:59

Senin

14:31-20:59

Selasa

14:31-20:59

Rabu

14:31-20:59

Kamis

14:31-20:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

349754982400

Saham yang Beredar

2407620096

Tanggal Penghasilan (Berikutnya)

2001-06-13

Hasil Div

2025-03-04

Tanggal Non-Dividen

2025-02-18

Proyeksi tingkat dividen tahunan

4.96

Proyeksi hasil dividen tahunan

0.0335

EPS

5.8

Pelajari lebih lanjut tentang instrumen ini

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Trustpilot
Live Chat